Clindamycin and erythromycin inhibit protein synthesis by irreversibly binding to the ribosomal 50S subunit of P. acnes (Physician's Desk Reference, 2001). Whereas erythromycin is bactericidal ...
The US Food and Drug Administration (FDA) approved Iterum Therapeutics’ (Nasdaq: ITRM) Orlynvah (sulopenem etzadroxil and probenecid) oral sulopenem) for the treatment of uncomplicated urinary tract ...
ORLYNVAHâ„¢ is the first oral penem antibiotic to be approved in the U.S. and represents a new option for patients with limited or no alternative oral antibacterial treatments. The FDA's decision is ...
On Wednesday, the FDA accepted GSK plc’s (NYSE:GSK) marketing application seeking approval for gepotidacin, an investigational, oral antibiotic for adult and adolescent females with ...
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Institute of Health Policy, Management ...
In patients with recurrent UTIs, oral immune stimulation by oral immunostimulant ... Hyperglycemia of ≥11.1 mmol/l (≥200 mg/dl) in diabetic patients leads to immune suppression of different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback